Rossari Biotech Limited has informed the Exchange regarding a Press Release dated October 15, 2025, titled "Rossari Biotech announces Q2 FY26 results".
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech Limited has filed a press release dated October 15, 2025, announcing its financial results for the second quarter of FY26 (quarter ending September 2025). The filing is a formal intimation to the stock exchanges about the release of quarterly results. The actual financial figures, revenue, profit, and other key metrics are contained in the press release itself, which has not been reproduced in this filing. Investors would need to refer to the company's investor relations page or the BSE/NSE filings section for the detailed Q2 FY26 numbers.
This is a routine quarterly results filing and does not by itself move the stock. The actual price reaction will depend on the revenue, EBITDA, and profit numbers in the detailed results compared to street estimates.